SCHEMBL26435452

SCHEMBL26435452

c1ccc2c(c1)cc(-c1ccc(-c3nc(-c4cccc5ccc6ccccc6c45)nc(-c4cccc5sc6ccccc6c45)n3)cc1)c1ccccc12

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.35
HSD17B10 Q99714 4/20 0.35
HPGD P15428 4/20 0.35
L3MBTL1 Q9Y468 3/20 0.35
HIF1A Q16665 2/20 0.35
TSHR P16473 2/20 0.35
MAPK1 P28482 2/20 0.35
CASP1 P29466 1/20 0.35
CYP11B1 P15538 1/20 0.35
NQO2 P16083 2/20 0.34
NQO1 P15559 1/20 0.34
CYP1A2 P05177 2/20 0.33
ERBB2 P04626 1/20 0.33
FYN P06241 1/20 0.33
MAOA P21397 1/20 0.33
ACHE P22303 1/20 0.33
AHR P35869 1/20 0.33
F9 P00740 1/20 0.32
ALOX5 P09917 1/20 0.32
SLC9A1 P19634 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24306432 0.92 CYP11B1 (0.40) ALDH1A1HSD17B10HPGDL3MBTL1HIF1A
SCHEMBL26435404 0.91 L3MBTL1 (0.34) ALDH1A1HSD17B10HPGDL3MBTL1HIF1A
SCHEMBL26435374 0.91 ALDH1A1 (0.34) ALDH1A1HSD17B10HPGDL3MBTL1HIF1A
SCHEMBL26435457 0.91 CYP1A2 (0.37) ALDH1A1HSD17B10HPGDL3MBTL1HIF1A
SCHEMBL26435425 0.90 HDAC8 (0.38) ALDH1A1HSD17B10HPGDL3MBTL1TSHR
SCHEMBL24306441 0.90 L3MBTL1 (0.39) ALDH1A1HSD17B10HPGDL3MBTL1HIF1A
SCHEMBL21148498 0.89 L3MBTL1 (0.40) ALDH1A1HSD17B10HPGDL3MBTL1HIF1A
SCHEMBL21149247 0.89 L3MBTL1 (0.40) ALDH1A1HSD17B10HPGDL3MBTL1HIF1A
SCHEMBL26047246 0.88 F9 (0.36) ALDH1A1HSD17B10HPGDL3MBTL1HIF1A
SCHEMBL21148501 0.88 ALDH1A1 (0.37) ALDH1A1HSD17B10HPGDL3MBTL1HIF1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230320205-A1 NITROGEN-CONTAINING COMPOUND, ORGANIC ELECTROLUMINESCENT DEVICE, AND ELECTRONIC APPARATUS SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD. (CN) 2023-10-05 US disclosed
US-20230320205-A1 NITROGEN-CONTAINING COMPOUND, ORGANIC ELECTROLUMINESCENT DEVICE, AND ELECTRONIC APPARATUS SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD. (CN) 2023-10-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230320205-A1 NITROGEN-CONTAINING COMPOUND, ORGANIC ELECTROLUMINESCENT DEVICE, AND ELECTRONIC APPARATUS NOM1, MNS1, NOS1 ALDH1A1 1532/4885HSD17B10 4425/4885HPGD 2685/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.